Adaptimmune Therapeutics plc
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | -34.6% | -34.6% | -24.9% |
| FY2018 | -38.7% | -38.7% | -34.5% |
| FY2019 | -110.9% | -110.9% | -75.6% |
| FY2020 | -38.1% | -38.1% | -28.8% |
| FY2021 | -76.8% | -76.8% | -33.7% |
| FY2022 | -202.1% | -202.1% | -50.3% |
| FY2023 | -288.2% | -288.2% | -40.3% |
| FY2024 | -597.6% | -114.1% | -28.8% |